These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 17363013)

  • 1. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
    Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
    Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer.
    Vogel U; Overvad K; Wallin H; Tjønneland A; Nexø BA; Raaschou-Nielsen O
    Cancer Lett; 2005 May; 222(1):67-74. PubMed ID: 15837542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer.
    Raaschou-Nielsen O; Sørensen M; Overvad K; Tjønneland A; Vogel U
    Lung Cancer; 2008 Feb; 59(2):171-9. PubMed ID: 17913280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide excision repair pathway genes and oral premalignant lesions.
    Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
    Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China.
    Dong Z; Guo W; Zhou R; Wan L; Li Y; Wang N; Kuang G; Wang S
    J Clin Gastroenterol; 2008 Sep; 42(8):910-5. PubMed ID: 18645534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
    Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
    Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
    Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
    Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
    Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronuclei and chromosomal aberrations, important markers of ageing: possible association with XPC and XPD polymorphisms.
    Kazimírová A; Barancoková M; Dzupinková Z; Wsólová L; Dusinská M
    Mutat Res; 2009 Feb; 661(1-2):35-40. PubMed ID: 19027756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
    Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
    Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
    Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
    Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
    Batar B; Güven M; Bariş S; Celkan T; Yildiz I
    Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS-920: DNA repair gene polymorphisms, diet and colorectal cancer risk in Taiwan.
    Yeh CC; Hsieh LL; Tang R; Chang-Chieh CR; Sung FC
    Cancer Lett; 2005 Jun; 224(2):279-88. PubMed ID: 15914278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].
    Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Sun Y; Xu BH; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):972-5. PubMed ID: 16061005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.
    Benhamou S; Sarasin A
    Am J Epidemiol; 2005 Jan; 161(1):1-14. PubMed ID: 15615908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
    Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
    Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
    Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.